2025 HCPCS Code G9084
Oncology; disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t1-3, n0, m0 with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)
TAGS: adenocarcinoma colon invasive initially disease demonstration limited evidence predominant extent metastases establishedShort Description | Onc dx colon t1-3,n1-2,no pr |
HCPCS Action Code | N - No maintenance for this code |
HCPCS Coverage Code | C - Carrier judgment |
HCPCS Code Added Date | January 01, 2006 |
HCPCS Action Effective Date | January 01, 2007 |
HCPCS Pricing Indicator Code | 00 - Service not separately priced by part B (e.G., services not covered, bundled, used by part a only, etc.) |
HCPCS Type Of Service Code | 1 - Medical care |
HCPCS Multiple Pricing Indicator Code | 9 - Not applicable as HCPCS not priced separately by part B (pricing indicator is 00) or value is not established (pricing indicator is '99') |
HCPCS Anesthesia Base Unit Quantity | 0 |
HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- G0921 - Doc pt reas no assess
- G0922 - Type loc act not doc
- G1000 - Cdsm applied pathways
- G1001 - Cdsm evicore
- G1002 - Cdsm medcurrent
- G1003 - Cdsm medicalis
- G1004 - Cdsm ndsc
- G1005 - Cdsm nia
- G1006 - Cdsm test approp
- G1007 - Cdsm aim
- G1008 - Cdsm cranberry pk
- G1009 - Cdsm sage health
- G1010 - Cdsm stanson
- G1011 - Cdsm qualified nos
- G1012 - Cdsm agilemd
- G1013 - Cdsm evidencecare
- G1014 - Cdsm inveniqa
- G1015 - Cdsm reliant
- G1016 - Cdsm speed of care
- G1017 - Cdsm healthhelp